|4Jul 13, 4:48 PM ET

DesRosiers Caleb 4

4 · DAXOR CORP · Filed Jul 13, 2023

Insider Transaction Report

Form 4
Period: 2023-07-11
Transactions
  • Award

    Stock options (right to buy)

    2023-07-11+2,5002,500 total
    Exercise: $9.88Exp: 2028-07-11Common Stock (2,500 underlying)
Footnotes (2)
  • [F1]Stock options granted on July 11, 2022 are contingent on the approval of the Securities & Exchange Commission ("SEC") to amend the Daxor Corporation 2020 Incentive Compensation Plan (the "Plan")
  • [F2]The stock options will vest in three (3) installments - July 11, 2024 (833); July 11, 2025 (834); July 11, 2026 (666)

Documents

1 file
  • 4
    ownership.xmlPrimary